Victor from Finland

Registered at the short selling broker Capital, 5 minutes ago.

» Try Capital you too
67.7% of retail investor accounts lose money when trading CFDs with Capital.
Don't show again

CARA Therapeutics, Inc. (CARA) shares information

Cara Therapeutics Inc


24h Change

-2.91 %

CARA

Live rate: Market closed

Stock data per Friday 22 Sep, 2023

CARA
NASDAQ
1.72
1.72
1.67
-0.05 (-2.91%)
US Market is closed

Live Stock price in graph for Cara Therapeutics Inc (CARA)

  • Latest Volume

    561,633 (4.35 %)

  • Volume prev. day

    538,226

  • Avg. daily volume

    933,008

  • Market cap

    90,309,727

  • P/E ratio

    -0.81

  • Today high

    1.73 USD

  • Today low

    1.66 USD

  • 52 week high

    12.81 USD

  • 52 week low

    1.66 USD

  • YTD Change

    n/a

Quick links

 

Latest news about Cara Therapeutics Inc

Below you can find the most recent news posts about Cara Therapeutics Inc, primarily from US and UK based news sources.

Marijuana Stock Movers For September 19, 2023

Tuesday, 19 September 2023, 23:30:07
GAINERS: Maple Leaf Green World (OTC: MGWFF ) shares closed up 18.06% at $0.02 Heritage Cannabis Holding (OTC: HERTF ) shares closed up 13.72% at $0.01 Charlottes Web Holdings (OTC: CWBHF ) shares closed up 13.32% at $0.43 MJ Holdings (OTC: MJNE ) shares closed up 11.15% at $0.02 Leafbuyer Techs (OTC: LBUY ) shares closed up 8.23% at $0.07 GreenGro Technologies (OTC: GRNH ) shares closed up 5.66% at $0.00 Cara Therapeutics (NASDAQ: CARA ) shares closed up 3.19% at $1.94 1933 Industries (OTC: TGIFF ) shares closed up 3.12% at $0.02 LOSERS: Target Group (OTC: CBDY ) shares closed down 46.95% at $0.00 AusCann Group Holdings (OTC: ACNNF ) shares closed down 35.29% at $0.00 Item 9 Labs (OTC: INLB ) shares closed down 23.08% at $0.01 Kaya … Full story available on Benzinga.com
— Benzinga


CARA, AVGR and KA among healthcare movers

Monday, 18 September 2023, 16:00:30
Gainers: Avinger (AVGR) +67%.SeqLL SQL +57%.MIRA Pharmaceuticals (MIRA) +17%.Cibus (CBUS) +15%.Kineta (KA) +11%.Losers: STRATA Skin Sciences (SSKN) -31%.Canopy Growth…
— Seeking Alpha


Cannabis Stock Gainers And Losers From September 13, 2023

Wednesday, 13 September 2023, 23:30:07
GAINERS: Choom Holdings (OTC: CHOOF ) shares closed up 9900.00% at $0.0001 CNBX Pharmaceuticals (OTC: CNBX ) shares closed up 53.57% at $0.04 Trees (OTC: CANN ) shares closed up 32.61% at $0.15 1933 Industries (OTC: TGIFF ) shares closed up 23.43% at $0.02 Urban-gro (NASDAQ: UGRO ) shares closed up 11.02% at $1.41 Blueberries Medical (OTC: BBRRF ) shares closed up 9.69% at $0.02 Tetra Bio Pharma (OTC: TBPMF ) shares closed up 9.09% at $0.00 Cronos Group (NASDAQ: CRON ) shares closed up 8.44% at $2.44 Neptune Wellness Solns (NASDAQ: NEPT ) shares closed up 8.33% at $5.98 Kaya Holdings (OTC: KAYS ) shares closed up 7.14% at $0.05 Cara Therapeutics (NASDAQ: CARA ) shares closed up 5.81% at $1.82 Cannabix Technologies (OTC: BLOZF ) shares closed up 5.45% at $0.23 iAnthus Capital Hldgs … Full story available on Benzinga.com
— Benzinga


Cara Therapeutics, Inc. (CARA) to Present at the H.C. Wainwright 25th Annual Global Investment Conference

Tuesday, 5 September 2023, 14:50:14
Cara Therapeutics to Present at the H.C. Wainwright 25th Annual Global Investment Conference Cara Therapeutics, Inc. (Nasdaq: CARA), a commercial-stage biopharmaceutical company leading a new treatment paradigm to improve the lives of patients suffering from pruritus, today announced that Christopher Posner, President and Chief Executive Officer, will present at the H.C. Wainwright 25th Annual Global Investment Conference on Monday, September 11, 2023, at 9:00 a.m. EDT in New York, NY. A webcast of the presentation can be accessed under “Events & Presentations” in the Investors section of the Company’s website at www.CaraTherapeutics.com. An archived webcast recording will be available on the Cara website for approximately 30 days. About Cara Therapeutics Cara Therapeutics is a commercial-stage biopharmaceutical company leading a new treatment paradigm to improve the lives of patients suffering from pruritus. The Company’s KORSUVA® (difelikefalin) injection is the first and only FDA-approved treatment for moderate-to-severe pruritus associated with chronic kidney disease in adults undergoing hemodialysis.
— Marijuana Stocks


Cara Therapeutics to Present at the H.C. Wainwright 25th Annual Global Investment Conference

Tuesday, 5 September 2023, 13:00:00
STAMFORD, Conn., Sept. 05, 2023 (GLOBE NEWSWIRE) — Cara Therapeutics, Inc. (Nasdaq: CARA), a commercial-stage biopharmaceutical company leading a new treatment paradigm to improve the lives of patients suffering from pruritus, today announced that Christopher Posner, President and Chief Executive Officer, will present at the H.C. Wainwright 25 th Annual Global Investment Conference on Monday, September 11, 2023, at 9:00 a.m. EDT in New York, NY.
— GlobeNewswire


Trading broker recommendation

We recommend that you check out Capital.com as they have a very good selection of stocks available for both going short and long.

Rating: 9.57/10
Minimum deposit: €250 by bank
Description: Capital.com offer a large number of stocks for trading. Register an account today and check if they have CARA available or trade one of the many other CFD stocks they have.
Risk warning: 67.7% of retail investor accounts lose money when trading CFDs with Capital.